nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR7—epilepsy syndrome	0.185	0.424	CbGaD
Lurasidone—ADRA2A—epilepsy syndrome	0.158	0.363	CbGaD
Lurasidone—HTR2A—epilepsy syndrome	0.0929	0.213	CbGaD
Lurasidone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0183	0.0879	CbGbCtD
Lurasidone—CYP3A4—Felbamate—epilepsy syndrome	0.017	0.0817	CbGbCtD
Lurasidone—CYP3A4—Trimethadione—epilepsy syndrome	0.017	0.0817	CbGbCtD
Lurasidone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.016	0.0768	CbGbCtD
Lurasidone—CYP3A4—Clonazepam—epilepsy syndrome	0.0145	0.0695	CbGbCtD
Lurasidone—CYP3A4—Clobazam—epilepsy syndrome	0.0139	0.0666	CbGbCtD
Lurasidone—CYP3A4—Rufinamide—epilepsy syndrome	0.0118	0.0566	CbGbCtD
Lurasidone—CYP3A4—Carbamazepine—epilepsy syndrome	0.0115	0.0552	CbGbCtD
Lurasidone—CYP3A4—Primidone—epilepsy syndrome	0.0107	0.0515	CbGbCtD
Lurasidone—CYP3A4—Phenytoin—epilepsy syndrome	0.0103	0.0495	CbGbCtD
Lurasidone—CYP3A4—Propofol—epilepsy syndrome	0.00963	0.0462	CbGbCtD
Lurasidone—CYP3A4—Acetazolamide—epilepsy syndrome	0.0092	0.0441	CbGbCtD
Lurasidone—CYP3A4—Phenobarbital—epilepsy syndrome	0.0092	0.0441	CbGbCtD
Lurasidone—CYP3A4—Midazolam—epilepsy syndrome	0.00907	0.0435	CbGbCtD
Lurasidone—CYP3A4—Diazepam—epilepsy syndrome	0.00872	0.0418	CbGbCtD
Lurasidone—CYP3A4—Zonisamide—epilepsy syndrome	0.00852	0.0408	CbGbCtD
Lurasidone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00688	0.033	CbGbCtD
Lurasidone—CYP3A4—Topiramate—epilepsy syndrome	0.00621	0.0297	CbGbCtD
Lurasidone—HTR2A—phrenic nerve—epilepsy syndrome	0.00606	0.0958	CbGeAlD
Lurasidone—HTR7—locus ceruleus—epilepsy syndrome	0.00434	0.0686	CbGeAlD
Lurasidone—HTR7—vagus nerve—epilepsy syndrome	0.00332	0.0525	CbGeAlD
Lurasidone—HTR2A—locus ceruleus—epilepsy syndrome	0.00271	0.0428	CbGeAlD
Lurasidone—HTR7—pons—epilepsy syndrome	0.0025	0.0395	CbGeAlD
Lurasidone—HTR7—autonomic nervous system—epilepsy syndrome	0.00231	0.0364	CbGeAlD
Lurasidone—HTR2A—cerebellar cortex—epilepsy syndrome	0.00221	0.0349	CbGeAlD
Lurasidone—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00215	0.034	CbGeAlD
Lurasidone—HTR2A—vagus nerve—epilepsy syndrome	0.00207	0.0327	CbGeAlD
Lurasidone—HTR7—telencephalic ventricle—epilepsy syndrome	0.00206	0.0325	CbGeAlD
Lurasidone—DRD2—telencephalic ventricle—epilepsy syndrome	0.00195	0.0307	CbGeAlD
Lurasidone—HTR2A—pons—epilepsy syndrome	0.00156	0.0246	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—epilepsy syndrome	0.00144	0.0227	CbGeAlD
Lurasidone—HTR1A—ganglion—epilepsy syndrome	0.00134	0.0212	CbGeAlD
Lurasidone—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00128	0.0203	CbGeAlD
Lurasidone—HTR7—ganglion—epilepsy syndrome	0.00128	0.0202	CbGeAlD
Lurasidone—DRD2—ganglion—epilepsy syndrome	0.00121	0.0191	CbGeAlD
Lurasidone—HTR1A—hindbrain—epilepsy syndrome	0.00102	0.0161	CbGeAlD
Lurasidone—HTR7—hindbrain—epilepsy syndrome	0.000972	0.0154	CbGeAlD
Lurasidone—DRD2—hindbrain—epilepsy syndrome	0.000919	0.0145	CbGeAlD
Lurasidone—HTR2A—ganglion—epilepsy syndrome	0.000799	0.0126	CbGeAlD
Lurasidone—Ziprasidone—CHRM3—epilepsy syndrome	0.0007	0.188	CrCbGaD
Lurasidone—Ziprasidone—CHRM1—epilepsy syndrome	0.000653	0.175	CrCbGaD
Lurasidone—HTR2A—hindbrain—epilepsy syndrome	0.000606	0.00957	CbGeAlD
Lurasidone—HTR1A—brainstem—epilepsy syndrome	0.000583	0.00921	CbGeAlD
Lurasidone—HTR1A—forebrain—epilepsy syndrome	0.000562	0.00889	CbGeAlD
Lurasidone—HTR7—brainstem—epilepsy syndrome	0.000557	0.0088	CbGeAlD
Lurasidone—HTR7—forebrain—epilepsy syndrome	0.000538	0.00849	CbGeAlD
Lurasidone—Ziprasidone—CHRM2—epilepsy syndrome	0.000533	0.143	CrCbGaD
Lurasidone—Ziprasidone—HTR7—epilepsy syndrome	0.000531	0.142	CrCbGaD
Lurasidone—DRD2—brainstem—epilepsy syndrome	0.000527	0.00832	CbGeAlD
Lurasidone—HTR1A—telencephalon—epilepsy syndrome	0.000517	0.00817	CbGeAlD
Lurasidone—DRD2—forebrain—epilepsy syndrome	0.000508	0.00803	CbGeAlD
Lurasidone—HTR7—telencephalon—epilepsy syndrome	0.000494	0.00781	CbGeAlD
Lurasidone—DRD2—telencephalon—epilepsy syndrome	0.000467	0.00738	CbGeAlD
Lurasidone—Ziprasidone—ADRA2A—epilepsy syndrome	0.000455	0.122	CrCbGaD
Lurasidone—ADRA2C—telencephalon—epilepsy syndrome	0.000454	0.00718	CbGeAlD
Lurasidone—ADRA2A—forebrain—epilepsy syndrome	0.000394	0.00623	CbGeAlD
Lurasidone—HTR7—medulla oblongata—epilepsy syndrome	0.000388	0.00614	CbGeAlD
Lurasidone—HTR1A—midbrain—epilepsy syndrome	0.000371	0.00587	CbGeAlD
Lurasidone—ADRA2A—telencephalon—epilepsy syndrome	0.000362	0.00573	CbGeAlD
Lurasidone—HTR1A—spinal cord—epilepsy syndrome	0.000362	0.00573	CbGeAlD
Lurasidone—ADRA2C—medulla oblongata—epilepsy syndrome	0.000357	0.00564	CbGeAlD
Lurasidone—HTR7—midbrain—epilepsy syndrome	0.000355	0.00561	CbGeAlD
Lurasidone—HTR2A—brainstem—epilepsy syndrome	0.000347	0.00549	CbGeAlD
Lurasidone—Ziprasidone—SLC6A4—epilepsy syndrome	0.000347	0.0931	CrCbGaD
Lurasidone—HTR7—spinal cord—epilepsy syndrome	0.000346	0.00547	CbGeAlD
Lurasidone—DRD2—midbrain—epilepsy syndrome	0.000336	0.0053	CbGeAlD
Lurasidone—HTR2A—forebrain—epilepsy syndrome	0.000335	0.0053	CbGeAlD
Lurasidone—ADRA2C—midbrain—epilepsy syndrome	0.000326	0.00515	CbGeAlD
Lurasidone—HTR1A—head—epilepsy syndrome	0.000322	0.00509	CbGeAlD
Lurasidone—ADRA2C—spinal cord—epilepsy syndrome	0.000318	0.00503	CbGeAlD
Lurasidone—HTR2A—telencephalon—epilepsy syndrome	0.000308	0.00487	CbGeAlD
Lurasidone—HTR7—head—epilepsy syndrome	0.000308	0.00486	CbGeAlD
Lurasidone—HTR1A—nervous system—epilepsy syndrome	0.000305	0.00482	CbGeAlD
Lurasidone—HTR1A—central nervous system—epilepsy syndrome	0.000294	0.00464	CbGeAlD
Lurasidone—HTR7—nervous system—epilepsy syndrome	0.000292	0.00461	CbGeAlD
Lurasidone—DRD2—head—epilepsy syndrome	0.000291	0.0046	CbGeAlD
Lurasidone—HTR1A—cerebellum—epilepsy syndrome	0.000287	0.00454	CbGeAlD
Lurasidone—ADRA2A—medulla oblongata—epilepsy syndrome	0.000285	0.0045	CbGeAlD
Lurasidone—ADRA2C—head—epilepsy syndrome	0.000283	0.00447	CbGeAlD
Lurasidone—HTR7—central nervous system—epilepsy syndrome	0.000281	0.00444	CbGeAlD
Lurasidone—DRD2—nervous system—epilepsy syndrome	0.000276	0.00436	CbGeAlD
Lurasidone—HTR7—cerebellum—epilepsy syndrome	0.000275	0.00434	CbGeAlD
Lurasidone—ADRA2C—nervous system—epilepsy syndrome	0.000268	0.00424	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—epilepsy syndrome	0.000267	0.0715	CrCbGaD
Lurasidone—DRD2—central nervous system—epilepsy syndrome	0.000266	0.0042	CbGeAlD
Lurasidone—ADRA2A—midbrain—epilepsy syndrome	0.00026	0.00411	CbGeAlD
Lurasidone—DRD2—cerebellum—epilepsy syndrome	0.00026	0.0041	CbGeAlD
Lurasidone—ADRA2C—central nervous system—epilepsy syndrome	0.000258	0.00408	CbGeAlD
Lurasidone—ADRA2A—spinal cord—epilepsy syndrome	0.000254	0.00401	CbGeAlD
Lurasidone—ADRA2C—cerebellum—epilepsy syndrome	0.000252	0.00399	CbGeAlD
Lurasidone—Ziprasidone—CYP2D6—epilepsy syndrome	0.000244	0.0654	CrCbGaD
Lurasidone—HTR2A—medulla oblongata—epilepsy syndrome	0.000242	0.00383	CbGeAlD
Lurasidone—HTR1A—brain—epilepsy syndrome	0.000233	0.00369	CbGeAlD
Lurasidone—ADRA2A—head—epilepsy syndrome	0.000226	0.00357	CbGeAlD
Lurasidone—HTR7—brain—epilepsy syndrome	0.000223	0.00352	CbGeAlD
Lurasidone—HTR2A—midbrain—epilepsy syndrome	0.000221	0.0035	CbGeAlD
Lurasidone—HTR2A—spinal cord—epilepsy syndrome	0.000216	0.00341	CbGeAlD
Lurasidone—ADRA2A—nervous system—epilepsy syndrome	0.000214	0.00338	CbGeAlD
Lurasidone—DRD2—brain—epilepsy syndrome	0.000211	0.00333	CbGeAlD
Lurasidone—ADRA2A—central nervous system—epilepsy syndrome	0.000206	0.00326	CbGeAlD
Lurasidone—ADRA2C—brain—epilepsy syndrome	0.000205	0.00324	CbGeAlD
Lurasidone—ADRA2A—cerebellum—epilepsy syndrome	0.000201	0.00318	CbGeAlD
Lurasidone—HTR2A—head—epilepsy syndrome	0.000192	0.00303	CbGeAlD
Lurasidone—HTR2A—nervous system—epilepsy syndrome	0.000182	0.00288	CbGeAlD
Lurasidone—HTR2A—central nervous system—epilepsy syndrome	0.000175	0.00277	CbGeAlD
Lurasidone—HTR2A—cerebellum—epilepsy syndrome	0.000171	0.00271	CbGeAlD
Lurasidone—CYP3A4—nervous system—epilepsy syndrome	0.000168	0.00266	CbGeAlD
Lurasidone—ADRA2A—brain—epilepsy syndrome	0.000164	0.00258	CbGeAlD
Lurasidone—CYP3A4—central nervous system—epilepsy syndrome	0.000162	0.00256	CbGeAlD
Lurasidone—HTR2A—brain—epilepsy syndrome	0.000139	0.0022	CbGeAlD
Lurasidone—Asthenia—Felbamate—epilepsy syndrome	5.86e-05	0.000297	CcSEcCtD
Lurasidone—Vision blurred—Pregabalin—epilepsy syndrome	5.85e-05	0.000296	CcSEcCtD
Lurasidone—Myalgia—Valproic Acid—epilepsy syndrome	5.85e-05	0.000296	CcSEcCtD
Lurasidone—Anxiety—Valproic Acid—epilepsy syndrome	5.83e-05	0.000295	CcSEcCtD
Lurasidone—Tremor—Pregabalin—epilepsy syndrome	5.82e-05	0.000295	CcSEcCtD
Lurasidone—Rash—Midazolam—epilepsy syndrome	5.81e-05	0.000294	CcSEcCtD
Lurasidone—Dizziness—Fosphenytoin—epilepsy syndrome	5.81e-05	0.000294	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	5.81e-05	0.000294	CcSEcCtD
Lurasidone—Dermatitis—Midazolam—epilepsy syndrome	5.81e-05	0.000294	CcSEcCtD
Lurasidone—Vomiting—Levetiracetam—epilepsy syndrome	5.79e-05	0.000293	CcSEcCtD
Lurasidone—Pruritus—Felbamate—epilepsy syndrome	5.78e-05	0.000292	CcSEcCtD
Lurasidone—Abdominal pain—Carbamazepine—epilepsy syndrome	5.77e-05	0.000292	CcSEcCtD
Lurasidone—Diarrhoea—Diazepam—epilepsy syndrome	5.77e-05	0.000292	CcSEcCtD
Lurasidone—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.77e-05	0.000292	CcSEcCtD
Lurasidone—Rash—Levetiracetam—epilepsy syndrome	5.74e-05	0.000291	CcSEcCtD
Lurasidone—Anaemia—Pregabalin—epilepsy syndrome	5.74e-05	0.000291	CcSEcCtD
Lurasidone—Dermatitis—Levetiracetam—epilepsy syndrome	5.74e-05	0.00029	CcSEcCtD
Lurasidone—Asthenia—Zonisamide—epilepsy syndrome	5.73e-05	0.00029	CcSEcCtD
Lurasidone—Mental disorder—Gabapentin—epilepsy syndrome	5.73e-05	0.00029	CcSEcCtD
Lurasidone—Agranulocytosis—Topiramate—epilepsy syndrome	5.72e-05	0.00029	CcSEcCtD
Lurasidone—Dry mouth—Valproic Acid—epilepsy syndrome	5.72e-05	0.00029	CcSEcCtD
Lurasidone—Agitation—Pregabalin—epilepsy syndrome	5.71e-05	0.000289	CcSEcCtD
Lurasidone—Malnutrition—Gabapentin—epilepsy syndrome	5.7e-05	0.000288	CcSEcCtD
Lurasidone—Angioedema—Pregabalin—epilepsy syndrome	5.68e-05	0.000287	CcSEcCtD
Lurasidone—Dizziness—Vigabatrin—epilepsy syndrome	5.67e-05	0.000287	CcSEcCtD
Lurasidone—Pruritus—Zonisamide—epilepsy syndrome	5.65e-05	0.000286	CcSEcCtD
Lurasidone—Flatulence—Gabapentin—epilepsy syndrome	5.61e-05	0.000284	CcSEcCtD
Lurasidone—Bradycardia—Topiramate—epilepsy syndrome	5.6e-05	0.000284	CcSEcCtD
Lurasidone—Malaise—Pregabalin—epilepsy syndrome	5.6e-05	0.000284	CcSEcCtD
Lurasidone—Nausea—Propofol—epilepsy syndrome	5.6e-05	0.000283	CcSEcCtD
Lurasidone—Vomiting—Fosphenytoin—epilepsy syndrome	5.59e-05	0.000283	CcSEcCtD
Lurasidone—Diarrhoea—Felbamate—epilepsy syndrome	5.59e-05	0.000283	CcSEcCtD
Lurasidone—Vertigo—Pregabalin—epilepsy syndrome	5.58e-05	0.000283	CcSEcCtD
Lurasidone—Abdominal pain—Lamotrigine—epilepsy syndrome	5.58e-05	0.000282	CcSEcCtD
Lurasidone—Dizziness—Diazepam—epilepsy syndrome	5.58e-05	0.000282	CcSEcCtD
Lurasidone—Infection—Valproic Acid—epilepsy syndrome	5.57e-05	0.000282	CcSEcCtD
Lurasidone—Syncope—Pregabalin—epilepsy syndrome	5.57e-05	0.000282	CcSEcCtD
Lurasidone—Leukopenia—Pregabalin—epilepsy syndrome	5.56e-05	0.000282	CcSEcCtD
Lurasidone—Rash—Fosphenytoin—epilepsy syndrome	5.54e-05	0.000281	CcSEcCtD
Lurasidone—Dermatitis—Fosphenytoin—epilepsy syndrome	5.54e-05	0.00028	CcSEcCtD
Lurasidone—Asthenia—Clonazepam—epilepsy syndrome	5.53e-05	0.00028	CcSEcCtD
Lurasidone—Back pain—Gabapentin—epilepsy syndrome	5.51e-05	0.000279	CcSEcCtD
Lurasidone—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.5e-05	0.000278	CcSEcCtD
Lurasidone—Asthenia—Phenytoin—epilepsy syndrome	5.49e-05	0.000278	CcSEcCtD
Lurasidone—Nausea—Midazolam—epilepsy syndrome	5.48e-05	0.000277	CcSEcCtD
Lurasidone—Muscle spasms—Gabapentin—epilepsy syndrome	5.48e-05	0.000277	CcSEcCtD
Lurasidone—Tachycardia—Valproic Acid—epilepsy syndrome	5.47e-05	0.000277	CcSEcCtD
Lurasidone—Diarrhoea—Zonisamide—epilepsy syndrome	5.47e-05	0.000277	CcSEcCtD
Lurasidone—Loss of consciousness—Pregabalin—epilepsy syndrome	5.46e-05	0.000276	CcSEcCtD
Lurasidone—Asthenia—Oxcarbazepine—epilepsy syndrome	5.46e-05	0.000276	CcSEcCtD
Lurasidone—Pruritus—Clonazepam—epilepsy syndrome	5.45e-05	0.000276	CcSEcCtD
Lurasidone—Vomiting—Vigabatrin—epilepsy syndrome	5.45e-05	0.000276	CcSEcCtD
Lurasidone—Skin disorder—Valproic Acid—epilepsy syndrome	5.45e-05	0.000276	CcSEcCtD
Lurasidone—Urinary tract disorder—Topiramate—epilepsy syndrome	5.44e-05	0.000275	CcSEcCtD
Lurasidone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.42e-05	0.000274	CcSEcCtD
Lurasidone—Pruritus—Phenytoin—epilepsy syndrome	5.41e-05	0.000274	CcSEcCtD
Lurasidone—Connective tissue disorder—Topiramate—epilepsy syndrome	5.41e-05	0.000274	CcSEcCtD
Lurasidone—Nausea—Levetiracetam—epilepsy syndrome	5.41e-05	0.000274	CcSEcCtD
Lurasidone—Rash—Vigabatrin—epilepsy syndrome	5.4e-05	0.000274	CcSEcCtD
Lurasidone—Dizziness—Felbamate—epilepsy syndrome	5.4e-05	0.000273	CcSEcCtD
Lurasidone—Dermatitis—Vigabatrin—epilepsy syndrome	5.4e-05	0.000273	CcSEcCtD
Lurasidone—Urethral disorder—Topiramate—epilepsy syndrome	5.4e-05	0.000273	CcSEcCtD
Lurasidone—Pruritus—Oxcarbazepine—epilepsy syndrome	5.38e-05	0.000273	CcSEcCtD
Lurasidone—Convulsion—Pregabalin—epilepsy syndrome	5.38e-05	0.000273	CcSEcCtD
Lurasidone—Vision blurred—Gabapentin—epilepsy syndrome	5.37e-05	0.000272	CcSEcCtD
Lurasidone—Hypertension—Pregabalin—epilepsy syndrome	5.36e-05	0.000272	CcSEcCtD
Lurasidone—Vomiting—Diazepam—epilepsy syndrome	5.36e-05	0.000272	CcSEcCtD
Lurasidone—Tremor—Gabapentin—epilepsy syndrome	5.34e-05	0.00027	CcSEcCtD
Lurasidone—Rash—Diazepam—epilepsy syndrome	5.32e-05	0.000269	CcSEcCtD
Lurasidone—Dermatitis—Diazepam—epilepsy syndrome	5.31e-05	0.000269	CcSEcCtD
Lurasidone—Myalgia—Pregabalin—epilepsy syndrome	5.29e-05	0.000268	CcSEcCtD
Lurasidone—Dizziness—Zonisamide—epilepsy syndrome	5.28e-05	0.000268	CcSEcCtD
Lurasidone—Anxiety—Pregabalin—epilepsy syndrome	5.27e-05	0.000267	CcSEcCtD
Lurasidone—Diarrhoea—Clonazepam—epilepsy syndrome	5.27e-05	0.000267	CcSEcCtD
Lurasidone—Anaemia—Gabapentin—epilepsy syndrome	5.26e-05	0.000267	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.25e-05	0.000266	CcSEcCtD
Lurasidone—Hypotension—Valproic Acid—epilepsy syndrome	5.24e-05	0.000265	CcSEcCtD
Lurasidone—Asthenia—Carbamazepine—epilepsy syndrome	5.24e-05	0.000265	CcSEcCtD
Lurasidone—Agitation—Gabapentin—epilepsy syndrome	5.23e-05	0.000265	CcSEcCtD
Lurasidone—Diarrhoea—Phenytoin—epilepsy syndrome	5.23e-05	0.000265	CcSEcCtD
Lurasidone—Nausea—Fosphenytoin—epilepsy syndrome	5.22e-05	0.000264	CcSEcCtD
Lurasidone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.21e-05	0.000264	CcSEcCtD
Lurasidone—Angioedema—Gabapentin—epilepsy syndrome	5.2e-05	0.000264	CcSEcCtD
Lurasidone—Vomiting—Felbamate—epilepsy syndrome	5.19e-05	0.000263	CcSEcCtD
Lurasidone—Dry mouth—Pregabalin—epilepsy syndrome	5.17e-05	0.000262	CcSEcCtD
Lurasidone—Pruritus—Carbamazepine—epilepsy syndrome	5.17e-05	0.000262	CcSEcCtD
Lurasidone—Rash—Felbamate—epilepsy syndrome	5.15e-05	0.000261	CcSEcCtD
Lurasidone—Eye disorder—Topiramate—epilepsy syndrome	5.14e-05	0.00026	CcSEcCtD
Lurasidone—Dermatitis—Felbamate—epilepsy syndrome	5.14e-05	0.00026	CcSEcCtD
Lurasidone—Malaise—Gabapentin—epilepsy syndrome	5.14e-05	0.00026	CcSEcCtD
Lurasidone—Vertigo—Gabapentin—epilepsy syndrome	5.12e-05	0.000259	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.11e-05	0.000259	CcSEcCtD
Lurasidone—Cardiac disorder—Topiramate—epilepsy syndrome	5.11e-05	0.000259	CcSEcCtD
Lurasidone—Syncope—Gabapentin—epilepsy syndrome	5.11e-05	0.000259	CcSEcCtD
Lurasidone—Leukopenia—Gabapentin—epilepsy syndrome	5.1e-05	0.000258	CcSEcCtD
Lurasidone—Dizziness—Clonazepam—epilepsy syndrome	5.09e-05	0.000258	CcSEcCtD
Lurasidone—Nausea—Vigabatrin—epilepsy syndrome	5.09e-05	0.000258	CcSEcCtD
Lurasidone—Vomiting—Zonisamide—epilepsy syndrome	5.08e-05	0.000257	CcSEcCtD
Lurasidone—Insomnia—Valproic Acid—epilepsy syndrome	5.07e-05	0.000257	CcSEcCtD
Lurasidone—Asthenia—Lamotrigine—epilepsy syndrome	5.06e-05	0.000256	CcSEcCtD
Lurasidone—Dizziness—Phenytoin—epilepsy syndrome	5.06e-05	0.000256	CcSEcCtD
Lurasidone—Rash—Zonisamide—epilepsy syndrome	5.04e-05	0.000255	CcSEcCtD
Lurasidone—Infection—Pregabalin—epilepsy syndrome	5.04e-05	0.000255	CcSEcCtD
Lurasidone—Dermatitis—Zonisamide—epilepsy syndrome	5.03e-05	0.000255	CcSEcCtD
Lurasidone—Dizziness—Oxcarbazepine—epilepsy syndrome	5.03e-05	0.000255	CcSEcCtD
Lurasidone—Nausea—Diazepam—epilepsy syndrome	5.01e-05	0.000254	CcSEcCtD
Lurasidone—Loss of consciousness—Gabapentin—epilepsy syndrome	5.01e-05	0.000253	CcSEcCtD
Lurasidone—Dyspnoea—Valproic Acid—epilepsy syndrome	5e-05	0.000253	CcSEcCtD
Lurasidone—Diarrhoea—Carbamazepine—epilepsy syndrome	5e-05	0.000253	CcSEcCtD
Lurasidone—Angiopathy—Topiramate—epilepsy syndrome	4.99e-05	0.000253	CcSEcCtD
Lurasidone—Pruritus—Lamotrigine—epilepsy syndrome	4.99e-05	0.000253	CcSEcCtD
Lurasidone—Shock—Pregabalin—epilepsy syndrome	4.99e-05	0.000253	CcSEcCtD
Lurasidone—Somnolence—Valproic Acid—epilepsy syndrome	4.99e-05	0.000252	CcSEcCtD
Lurasidone—Nervous system disorder—Pregabalin—epilepsy syndrome	4.97e-05	0.000252	CcSEcCtD
Lurasidone—Tachycardia—Pregabalin—epilepsy syndrome	4.95e-05	0.000251	CcSEcCtD
Lurasidone—Dyspepsia—Valproic Acid—epilepsy syndrome	4.94e-05	0.00025	CcSEcCtD
Lurasidone—Convulsion—Gabapentin—epilepsy syndrome	4.94e-05	0.00025	CcSEcCtD
Lurasidone—Skin disorder—Pregabalin—epilepsy syndrome	4.92e-05	0.000249	CcSEcCtD
Lurasidone—Hypertension—Gabapentin—epilepsy syndrome	4.92e-05	0.000249	CcSEcCtD
Lurasidone—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.9e-05	0.000248	CcSEcCtD
Lurasidone—Vomiting—Clonazepam—epilepsy syndrome	4.9e-05	0.000248	CcSEcCtD
Lurasidone—Decreased appetite—Valproic Acid—epilepsy syndrome	4.87e-05	0.000247	CcSEcCtD
Lurasidone—Vomiting—Phenytoin—epilepsy syndrome	4.86e-05	0.000246	CcSEcCtD
Lurasidone—Rash—Clonazepam—epilepsy syndrome	4.86e-05	0.000246	CcSEcCtD
Lurasidone—Dermatitis—Clonazepam—epilepsy syndrome	4.85e-05	0.000246	CcSEcCtD
Lurasidone—Myalgia—Gabapentin—epilepsy syndrome	4.85e-05	0.000246	CcSEcCtD
Lurasidone—Nausea—Felbamate—epilepsy syndrome	4.85e-05	0.000246	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.84e-05	0.000245	CcSEcCtD
Lurasidone—Vomiting—Oxcarbazepine—epilepsy syndrome	4.84e-05	0.000245	CcSEcCtD
Lurasidone—Fatigue—Valproic Acid—epilepsy syndrome	4.83e-05	0.000245	CcSEcCtD
Lurasidone—Anxiety—Gabapentin—epilepsy syndrome	4.83e-05	0.000245	CcSEcCtD
Lurasidone—Dizziness—Carbamazepine—epilepsy syndrome	4.83e-05	0.000244	CcSEcCtD
Lurasidone—Diarrhoea—Lamotrigine—epilepsy syndrome	4.83e-05	0.000244	CcSEcCtD
Lurasidone—Rash—Phenytoin—epilepsy syndrome	4.82e-05	0.000244	CcSEcCtD
Lurasidone—Mental disorder—Topiramate—epilepsy syndrome	4.82e-05	0.000244	CcSEcCtD
Lurasidone—Dermatitis—Phenytoin—epilepsy syndrome	4.82e-05	0.000244	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.82e-05	0.000244	CcSEcCtD
Lurasidone—Rash—Oxcarbazepine—epilepsy syndrome	4.8e-05	0.000243	CcSEcCtD
Lurasidone—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.79e-05	0.000243	CcSEcCtD
Lurasidone—Malnutrition—Topiramate—epilepsy syndrome	4.79e-05	0.000243	CcSEcCtD
Lurasidone—Nausea—Zonisamide—epilepsy syndrome	4.75e-05	0.00024	CcSEcCtD
Lurasidone—Dry mouth—Gabapentin—epilepsy syndrome	4.74e-05	0.00024	CcSEcCtD
Lurasidone—Hypotension—Pregabalin—epilepsy syndrome	4.74e-05	0.00024	CcSEcCtD
Lurasidone—Flatulence—Topiramate—epilepsy syndrome	4.72e-05	0.000239	CcSEcCtD
Lurasidone—Dizziness—Lamotrigine—epilepsy syndrome	4.67e-05	0.000236	CcSEcCtD
Lurasidone—Vomiting—Carbamazepine—epilepsy syndrome	4.64e-05	0.000235	CcSEcCtD
Lurasidone—Back pain—Topiramate—epilepsy syndrome	4.64e-05	0.000235	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.62e-05	0.000234	CcSEcCtD
Lurasidone—Infection—Gabapentin—epilepsy syndrome	4.62e-05	0.000234	CcSEcCtD
Lurasidone—Muscle spasms—Topiramate—epilepsy syndrome	4.61e-05	0.000233	CcSEcCtD
Lurasidone—Rash—Carbamazepine—epilepsy syndrome	4.6e-05	0.000233	CcSEcCtD
Lurasidone—Dermatitis—Carbamazepine—epilepsy syndrome	4.6e-05	0.000233	CcSEcCtD
Lurasidone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.59e-05	0.000232	CcSEcCtD
Lurasidone—Insomnia—Pregabalin—epilepsy syndrome	4.59e-05	0.000232	CcSEcCtD
Lurasidone—Nausea—Clonazepam—epilepsy syndrome	4.57e-05	0.000232	CcSEcCtD
Lurasidone—Shock—Gabapentin—epilepsy syndrome	4.57e-05	0.000232	CcSEcCtD
Lurasidone—Nervous system disorder—Gabapentin—epilepsy syndrome	4.56e-05	0.000231	CcSEcCtD
Lurasidone—Nausea—Phenytoin—epilepsy syndrome	4.54e-05	0.00023	CcSEcCtD
Lurasidone—Tachycardia—Gabapentin—epilepsy syndrome	4.54e-05	0.00023	CcSEcCtD
Lurasidone—Dyspnoea—Pregabalin—epilepsy syndrome	4.52e-05	0.000229	CcSEcCtD
Lurasidone—Nausea—Oxcarbazepine—epilepsy syndrome	4.52e-05	0.000229	CcSEcCtD
Lurasidone—Vision blurred—Topiramate—epilepsy syndrome	4.52e-05	0.000229	CcSEcCtD
Lurasidone—Skin disorder—Gabapentin—epilepsy syndrome	4.52e-05	0.000229	CcSEcCtD
Lurasidone—Somnolence—Pregabalin—epilepsy syndrome	4.51e-05	0.000228	CcSEcCtD
Lurasidone—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.49e-05	0.000228	CcSEcCtD
Lurasidone—Tremor—Topiramate—epilepsy syndrome	4.49e-05	0.000227	CcSEcCtD
Lurasidone—Vomiting—Lamotrigine—epilepsy syndrome	4.49e-05	0.000227	CcSEcCtD
Lurasidone—Rash—Lamotrigine—epilepsy syndrome	4.45e-05	0.000225	CcSEcCtD
Lurasidone—Dermatitis—Lamotrigine—epilepsy syndrome	4.45e-05	0.000225	CcSEcCtD
Lurasidone—Abdominal pain—Valproic Acid—epilepsy syndrome	4.43e-05	0.000224	CcSEcCtD
Lurasidone—Anaemia—Topiramate—epilepsy syndrome	4.43e-05	0.000224	CcSEcCtD
Lurasidone—Decreased appetite—Pregabalin—epilepsy syndrome	4.41e-05	0.000223	CcSEcCtD
Lurasidone—Agitation—Topiramate—epilepsy syndrome	4.4e-05	0.000223	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.38e-05	0.000222	CcSEcCtD
Lurasidone—Fatigue—Pregabalin—epilepsy syndrome	4.37e-05	0.000221	CcSEcCtD
Lurasidone—Hypotension—Gabapentin—epilepsy syndrome	4.34e-05	0.00022	CcSEcCtD
Lurasidone—Nausea—Carbamazepine—epilepsy syndrome	4.34e-05	0.00022	CcSEcCtD
Lurasidone—Malaise—Topiramate—epilepsy syndrome	4.32e-05	0.000219	CcSEcCtD
Lurasidone—Vertigo—Topiramate—epilepsy syndrome	4.31e-05	0.000218	CcSEcCtD
Lurasidone—Syncope—Topiramate—epilepsy syndrome	4.3e-05	0.000218	CcSEcCtD
Lurasidone—Leukopenia—Topiramate—epilepsy syndrome	4.29e-05	0.000217	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.24e-05	0.000214	CcSEcCtD
Lurasidone—Loss of consciousness—Topiramate—epilepsy syndrome	4.21e-05	0.000213	CcSEcCtD
Lurasidone—Insomnia—Gabapentin—epilepsy syndrome	4.2e-05	0.000213	CcSEcCtD
Lurasidone—Nausea—Lamotrigine—epilepsy syndrome	4.19e-05	0.000212	CcSEcCtD
Lurasidone—Convulsion—Topiramate—epilepsy syndrome	4.15e-05	0.00021	CcSEcCtD
Lurasidone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.15e-05	0.00021	CcSEcCtD
Lurasidone—Dyspnoea—Gabapentin—epilepsy syndrome	4.14e-05	0.00021	CcSEcCtD
Lurasidone—Hypertension—Topiramate—epilepsy syndrome	4.14e-05	0.000209	CcSEcCtD
Lurasidone—Somnolence—Gabapentin—epilepsy syndrome	4.13e-05	0.000209	CcSEcCtD
Lurasidone—Dyspepsia—Gabapentin—epilepsy syndrome	4.09e-05	0.000207	CcSEcCtD
Lurasidone—Myalgia—Topiramate—epilepsy syndrome	4.08e-05	0.000207	CcSEcCtD
Lurasidone—Anxiety—Topiramate—epilepsy syndrome	4.07e-05	0.000206	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.05e-05	0.000205	CcSEcCtD
Lurasidone—Decreased appetite—Gabapentin—epilepsy syndrome	4.04e-05	0.000205	CcSEcCtD
Lurasidone—Asthenia—Valproic Acid—epilepsy syndrome	4.02e-05	0.000204	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.01e-05	0.000203	CcSEcCtD
Lurasidone—Fatigue—Gabapentin—epilepsy syndrome	4.01e-05	0.000203	CcSEcCtD
Lurasidone—Abdominal pain—Pregabalin—epilepsy syndrome	4.01e-05	0.000203	CcSEcCtD
Lurasidone—Dry mouth—Topiramate—epilepsy syndrome	3.99e-05	0.000202	CcSEcCtD
Lurasidone—Pruritus—Valproic Acid—epilepsy syndrome	3.97e-05	0.000201	CcSEcCtD
Lurasidone—Infection—Topiramate—epilepsy syndrome	3.89e-05	0.000197	CcSEcCtD
Lurasidone—Shock—Topiramate—epilepsy syndrome	3.85e-05	0.000195	CcSEcCtD
Lurasidone—Diarrhoea—Valproic Acid—epilepsy syndrome	3.84e-05	0.000194	CcSEcCtD
Lurasidone—Nervous system disorder—Topiramate—epilepsy syndrome	3.84e-05	0.000194	CcSEcCtD
Lurasidone—Tachycardia—Topiramate—epilepsy syndrome	3.82e-05	0.000193	CcSEcCtD
Lurasidone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.8e-05	0.000192	CcSEcCtD
Lurasidone—Skin disorder—Topiramate—epilepsy syndrome	3.8e-05	0.000192	CcSEcCtD
Lurasidone—Hyperhidrosis—Topiramate—epilepsy syndrome	3.78e-05	0.000191	CcSEcCtD
Lurasidone—Dizziness—Valproic Acid—epilepsy syndrome	3.71e-05	0.000188	CcSEcCtD
Lurasidone—Abdominal pain—Gabapentin—epilepsy syndrome	3.67e-05	0.000186	CcSEcCtD
Lurasidone—Hypotension—Topiramate—epilepsy syndrome	3.65e-05	0.000185	CcSEcCtD
Lurasidone—Asthenia—Pregabalin—epilepsy syndrome	3.64e-05	0.000184	CcSEcCtD
Lurasidone—Pruritus—Pregabalin—epilepsy syndrome	3.59e-05	0.000182	CcSEcCtD
Lurasidone—Vomiting—Valproic Acid—epilepsy syndrome	3.57e-05	0.000181	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.56e-05	0.00018	CcSEcCtD
Lurasidone—Insomnia—Topiramate—epilepsy syndrome	3.54e-05	0.000179	CcSEcCtD
Lurasidone—Rash—Valproic Acid—epilepsy syndrome	3.54e-05	0.000179	CcSEcCtD
Lurasidone—Dermatitis—Valproic Acid—epilepsy syndrome	3.53e-05	0.000179	CcSEcCtD
Lurasidone—Dyspnoea—Topiramate—epilepsy syndrome	3.49e-05	0.000177	CcSEcCtD
Lurasidone—Somnolence—Topiramate—epilepsy syndrome	3.48e-05	0.000176	CcSEcCtD
Lurasidone—Diarrhoea—Pregabalin—epilepsy syndrome	3.47e-05	0.000176	CcSEcCtD
Lurasidone—Dyspepsia—Topiramate—epilepsy syndrome	3.44e-05	0.000174	CcSEcCtD
Lurasidone—Decreased appetite—Topiramate—epilepsy syndrome	3.4e-05	0.000172	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.38e-05	0.000171	CcSEcCtD
Lurasidone—Fatigue—Topiramate—epilepsy syndrome	3.37e-05	0.000171	CcSEcCtD
Lurasidone—Dizziness—Pregabalin—epilepsy syndrome	3.35e-05	0.00017	CcSEcCtD
Lurasidone—Asthenia—Gabapentin—epilepsy syndrome	3.34e-05	0.000169	CcSEcCtD
Lurasidone—Nausea—Valproic Acid—epilepsy syndrome	3.33e-05	0.000169	CcSEcCtD
Lurasidone—Pruritus—Gabapentin—epilepsy syndrome	3.29e-05	0.000167	CcSEcCtD
Lurasidone—Vomiting—Pregabalin—epilepsy syndrome	3.22e-05	0.000163	CcSEcCtD
Lurasidone—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.2e-05	0.000162	CcSEcCtD
Lurasidone—Rash—Pregabalin—epilepsy syndrome	3.2e-05	0.000162	CcSEcCtD
Lurasidone—Dermatitis—Pregabalin—epilepsy syndrome	3.19e-05	0.000162	CcSEcCtD
Lurasidone—Diarrhoea—Gabapentin—epilepsy syndrome	3.18e-05	0.000161	CcSEcCtD
Lurasidone—Abdominal pain—Topiramate—epilepsy syndrome	3.09e-05	0.000157	CcSEcCtD
Lurasidone—Dizziness—Gabapentin—epilepsy syndrome	3.07e-05	0.000156	CcSEcCtD
Lurasidone—Nausea—Pregabalin—epilepsy syndrome	3.01e-05	0.000152	CcSEcCtD
Lurasidone—Vomiting—Gabapentin—epilepsy syndrome	2.96e-05	0.00015	CcSEcCtD
Lurasidone—Rash—Gabapentin—epilepsy syndrome	2.93e-05	0.000148	CcSEcCtD
Lurasidone—Dermatitis—Gabapentin—epilepsy syndrome	2.93e-05	0.000148	CcSEcCtD
Lurasidone—Asthenia—Topiramate—epilepsy syndrome	2.81e-05	0.000142	CcSEcCtD
Lurasidone—Pruritus—Topiramate—epilepsy syndrome	2.77e-05	0.00014	CcSEcCtD
Lurasidone—Nausea—Gabapentin—epilepsy syndrome	2.76e-05	0.00014	CcSEcCtD
Lurasidone—Diarrhoea—Topiramate—epilepsy syndrome	2.68e-05	0.000135	CcSEcCtD
Lurasidone—Dizziness—Topiramate—epilepsy syndrome	2.59e-05	0.000131	CcSEcCtD
Lurasidone—Vomiting—Topiramate—epilepsy syndrome	2.49e-05	0.000126	CcSEcCtD
Lurasidone—Rash—Topiramate—epilepsy syndrome	2.47e-05	0.000125	CcSEcCtD
Lurasidone—Dermatitis—Topiramate—epilepsy syndrome	2.46e-05	0.000125	CcSEcCtD
Lurasidone—Nausea—Topiramate—epilepsy syndrome	2.32e-05	0.000118	CcSEcCtD
Lurasidone—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	5.42e-06	5.95e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GPX1—epilepsy syndrome	5.41e-06	5.94e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	5.39e-06	5.92e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	5.39e-06	5.92e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	5.39e-06	5.92e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	5.38e-06	5.91e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	5.37e-06	5.89e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	5.34e-06	5.86e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	5.33e-06	5.86e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—KDR—epilepsy syndrome	5.31e-06	5.83e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	5.26e-06	5.78e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—S100B—epilepsy syndrome	5.26e-06	5.77e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	5.25e-06	5.77e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.23e-06	5.74e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.23e-06	5.74e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SOCS3—epilepsy syndrome	5.21e-06	5.72e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	5.2e-06	5.71e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CDC42—epilepsy syndrome	5.19e-06	5.7e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	5.18e-06	5.68e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	5.16e-06	5.67e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—SRC—epilepsy syndrome	5.16e-06	5.67e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	5.13e-06	5.63e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PRKCB—epilepsy syndrome	5.11e-06	5.62e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.11e-06	5.62e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6ST—epilepsy syndrome	5.09e-06	5.59e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	5.08e-06	5.58e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	5.07e-06	5.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	5.07e-06	5.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	5.06e-06	5.55e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	5.05e-06	5.54e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	5.04e-06	5.54e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	5.04e-06	5.54e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	5.03e-06	5.52e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AVP—epilepsy syndrome	5.03e-06	5.52e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	5.02e-06	5.52e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	5.02e-06	5.51e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.01e-06	5.5e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	4.97e-06	5.46e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	4.97e-06	5.46e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	4.96e-06	5.45e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	4.95e-06	5.44e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	4.94e-06	5.42e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	4.93e-06	5.41e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.91e-06	5.4e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	4.91e-06	5.39e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CAT—epilepsy syndrome	4.86e-06	5.34e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	4.85e-06	5.33e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.82e-06	5.3e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	4.78e-06	5.25e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—S100B—epilepsy syndrome	4.77e-06	5.24e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	4.76e-06	5.23e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	4.75e-06	5.22e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	4.75e-06	5.22e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—AGT—epilepsy syndrome	4.75e-06	5.21e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	4.73e-06	5.19e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	4.72e-06	5.19e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	4.71e-06	5.17e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	4.71e-06	5.17e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	4.69e-06	5.15e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—POMC—epilepsy syndrome	4.66e-06	5.12e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—APOE—epilepsy syndrome	4.65e-06	5.11e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	4.65e-06	5.1e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	4.64e-06	5.09e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	4.62e-06	5.08e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	4.62e-06	5.08e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	4.61e-06	5.06e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	4.6e-06	5.05e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	4.59e-06	5.04e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	4.59e-06	5.04e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AVP—epilepsy syndrome	4.56e-06	5.01e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CCL2—epilepsy syndrome	4.56e-06	5.01e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	4.54e-06	4.99e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	4.52e-06	4.96e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.51e-06	4.95e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	4.49e-06	4.94e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	4.49e-06	4.93e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	4.44e-06	4.88e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	4.42e-06	4.85e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GPX1—epilepsy syndrome	4.4e-06	4.83e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	4.39e-06	4.83e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.38e-06	4.81e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	4.32e-06	4.75e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HES1—epilepsy syndrome	4.31e-06	4.74e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	4.27e-06	4.69e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	4.27e-06	4.69e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	4.24e-06	4.66e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	4.23e-06	4.64e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	4.22e-06	4.63e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FYN—epilepsy syndrome	4.19e-06	4.61e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	4.18e-06	4.59e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	4.18e-06	4.59e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	4.17e-06	4.58e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	4.13e-06	4.53e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—FGF2—epilepsy syndrome	4.12e-06	4.52e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	4.11e-06	4.52e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	4.11e-06	4.51e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	4.11e-06	4.51e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	4.1e-06	4.5e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	4.08e-06	4.48e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	4.03e-06	4.43e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	4.02e-06	4.41e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—POMC—epilepsy syndrome	4e-06	4.39e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NGF—epilepsy syndrome	3.99e-06	4.38e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	3.97e-06	4.36e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	3.97e-06	4.36e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	3.97e-06	4.36e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.96e-06	4.35e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.96e-06	4.35e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	3.95e-06	4.34e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	3.94e-06	4.32e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	3.92e-06	4.31e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	3.89e-06	4.27e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	3.88e-06	4.26e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	3.86e-06	4.24e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AGT—epilepsy syndrome	3.86e-06	4.23e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RELA—epilepsy syndrome	3.82e-06	4.2e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	3.82e-06	4.19e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	3.81e-06	4.18e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	3.8e-06	4.17e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	3.79e-06	4.16e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—APOE—epilepsy syndrome	3.78e-06	4.15e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	3.77e-06	4.15e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	3.75e-06	4.12e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MTOR—epilepsy syndrome	3.75e-06	4.12e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	3.74e-06	4.11e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	3.73e-06	4.1e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	3.67e-06	4.03e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	3.65e-06	4.01e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ALB—epilepsy syndrome	3.64e-06	4e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	3.61e-06	3.96e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	3.61e-06	3.96e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AGT—epilepsy syndrome	3.6e-06	3.95e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	3.57e-06	3.92e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	3.55e-06	3.9e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	3.54e-06	3.89e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOE—epilepsy syndrome	3.53e-06	3.87e-05	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—AKT1—epilepsy syndrome	3.48e-06	3.82e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	3.47e-06	3.81e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	3.47e-06	3.81e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—KDR—epilepsy syndrome	3.46e-06	3.8e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	3.45e-06	3.79e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	3.45e-06	3.79e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	3.4e-06	3.74e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	3.4e-06	3.73e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	3.38e-06	3.71e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—JUN—epilepsy syndrome	3.35e-06	3.68e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	3.34e-06	3.67e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	3.33e-06	3.65e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	3.31e-06	3.64e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	3.27e-06	3.6e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	3.27e-06	3.59e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	3.26e-06	3.58e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	3.26e-06	3.58e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—POMC—epilepsy syndrome	3.25e-06	3.56e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.23e-06	3.55e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	3.23e-06	3.54e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	3.22e-06	3.54e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	3.21e-06	3.52e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	3.19e-06	3.5e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	3.16e-06	3.47e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	3.16e-06	3.47e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.15e-06	3.45e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.13e-06	3.43e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	3.09e-06	3.4e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	3.05e-06	3.35e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—POMC—epilepsy syndrome	3.03e-06	3.33e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—SRC—epilepsy syndrome	3.01e-06	3.3e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	2.98e-06	3.28e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.98e-06	3.27e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.97e-06	3.26e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	2.97e-06	3.26e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ALB—epilepsy syndrome	2.96e-06	3.25e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	2.95e-06	3.24e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	2.93e-06	3.21e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	2.92e-06	3.2e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	2.83e-06	3.11e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.82e-06	3.1e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	2.78e-06	3.05e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	2.74e-06	3.01e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	2.71e-06	2.98e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	2.69e-06	2.95e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.69e-06	2.95e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	2.68e-06	2.94e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.68e-06	2.94e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	2.66e-06	2.92e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	2.64e-06	2.9e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	2.59e-06	2.84e-05	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.58e-06	2.83e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	2.56e-06	2.81e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.55e-06	2.8e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.52e-06	2.77e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TH—epilepsy syndrome	2.52e-06	2.76e-05	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.5e-06	2.74e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RELA—epilepsy syndrome	2.49e-06	2.73e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	2.48e-06	2.73e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	2.47e-06	2.72e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	2.45e-06	2.69e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	2.44e-06	2.68e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	2.42e-06	2.65e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	2.4e-06	2.64e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	2.4e-06	2.64e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	2.4e-06	2.63e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.34e-06	2.57e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	2.34e-06	2.57e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.27e-06	2.49e-05	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.27e-06	2.49e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	2.24e-06	2.46e-05	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.23e-06	2.45e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	2.23e-06	2.45e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	2.23e-06	2.45e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	2.21e-06	2.43e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	2.18e-06	2.4e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—JUN—epilepsy syndrome	2.18e-06	2.39e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.17e-06	2.38e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	2.16e-06	2.37e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	2.15e-06	2.36e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	2.12e-06	2.33e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.1e-06	2.31e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.1e-06	2.3e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.09e-06	2.29e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.07e-06	2.27e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	2.06e-06	2.26e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.03e-06	2.23e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.02e-06	2.22e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.01e-06	2.21e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.01e-06	2.21e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.96e-06	2.15e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.95e-06	2.14e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.92e-06	2.11e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.9e-06	2.09e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.9e-06	2.08e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.87e-06	2.06e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.87e-06	2.06e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	1.87e-06	2.05e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.84e-06	2.02e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.75e-06	1.92e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.7e-06	1.87e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.64e-06	1.8e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.61e-06	1.77e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—AKT1—epilepsy syndrome	1.6e-06	1.76e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.38e-06	1.52e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.38e-06	1.52e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.34e-06	1.47e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.3e-06	1.43e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.26e-06	1.38e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.22e-06	1.33e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.2e-06	1.31e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.1e-06	1.21e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.09e-06	1.19e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.54e-07	6.09e-06	CbGpPWpGaD
